NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-052-2022-0-EP-01 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES EP National Stage 23721501.7 Pending
NCI E-038-2024-0-US-01 ACYLOXYACYL HYDROLASE AND METHODS OF USE US 63/717,036 Expired
NCI E-229-2014-0-US-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION US CON 18/938,390 Pending
NICHD E-115-2022-0-IN-01 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL IN National Stage 202417085218 Pending
NHLBI E-119-2022-0-CN-01 SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE CN National Stage 202380038697.9 Pending
NHLBI E-061-2022-0-IL-01 SYSTEMS AND METHOD FOR SYNCHRONOUS CIRCUMFERENTIAL INTRAMYOCARDIAL RESYNCHRONIZATION AND PACING IL National Stage 316835 Abandoned
NICHD E-115-2022-0-BR-01 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL BR National Stage BR112024023023-6 Pending
NHLBI E-119-2022-0-US-02 SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE US National Stage 18/862,905 Pending
NCI E-048-2022-0-EP-01 COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS EP National Stage 23727442.8 Pending
NHLBI E-017-2024-2-US-01 Myocardial access guiding catheter US 63/716,158 Expired
NHLBI E-017-2024-1-US-01 SYSTEMS AND METHODS FOR AN ABLATION CATHETER FOR INTRAMYOCARDIAL ABLATION US 63/716,145 Expired
NHLBI E-222-2022-9-US-01 Catheters and Manipulators with Articulable Ends US CIP 18/937,001 Pending
NCI E-127-2018-0-JP-02 Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy JP DIV 2024-192788 Pending
NCI E-135-2019-0-RU-01 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 RU DIV 2024132889 Pending
NCI E-105-2023-0-PC-01 DNA METHYLATION-BASED CANCER DIAGNOSTICS PCT PCT PCT/US2024/054179 Abandoned
NHLBI E-061-2022-0-CN-01 SYSTEMS AND METHOD FOR SYNCHRONOUS CIRCUMFERENTIAL INTRAMYOCARDIAL RESYNCHRONIZATION AND PACING CN National Stage 202380037592.1 Abandoned
NEI E-192-2014-1-AU-12 Surgical Tool and Method for Ocular Tissue Transplantation AU DIV 2024259653 Pending
NCI E-048-2022-0-US-02 COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS US National Stage 18/861,737 Pending
NHLBI E-119-2022-0-EP-01 SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE EP National Stage 23728558.0 Pending
NHLBI E-061-2022-0-EP-01 SYSTEMS AND METHOD FOR SYNCHRONOUS CIRCUMFERENTIAL INTRAMYOCARDIAL RESYNCHRONIZATION AND PACING EP National Stage 23729551.4 Pending
NICHD E-229-2023-0-US-01 METHOD TO MEASURE TONICITIES AND THEIR EFFECT ON WATER EXCHANGE THROUGH SEMIPERMEABLE MEMBRANES US 63/713,789 Expired
NEI E-058-2018-0-AU-10 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS AU DIV 2024227758 Pending
NCI E-183-2017-0-AU-01 ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS AU DIV 2024227725 Pending
NCI E-237-2017-2-AU-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 AU DIV 2024227695 Pending
NIBIB E-118-2022-0-EP-01 MICROFLUIDIC DEVICES FOR EVALUATING FIBROSIS IN MATERIAL IMPLANTATION AND CANCER EP National Stage 23726232.4 Pending
NIDCR E-196-2021-0-US-02 LENS ARRAY BASED IMAGING SYSTEM WITH IMPROVED FIELD OF VIEW US National Stage 18/859,972 Pending
NIDCR E-196-2021-0-EP-01 LENS ARRAY BASED IMAGING SYSTEM WITH IMPROVED FIELD OF VIEW EP National Stage 23724989.1 Pending
NIBIB E-118-2022-0-JP-01 MICROFLUIDIC DEVICES FOR EVALUATING FIBROSIS IN MATERIAL IMPLANTATION AND CANCER JP National Stage 2024-563226 Abandoned
NIBIB E-118-2022-0-US-02 MICROFLUIDIC DEVICES FOR EVALUATING FIBROSIS IN MATERIAL IMPLANTATION AND CANCER US National Stage 18/859,345 Pending
NHLBI E-036-2022-0-EP-01 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS EP National Stage 23722117.1 Pending
NCI E-012-2025-0-US-01 Particle Scaffolds for Tissue Reconstruction US 63/710,652 Expired
NINDS E-113-2022-1-US-01 RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2 US National Stage 18/859,027 Pending
CC E-217-2024-0-US-01 WEARABLE SPIROMETRY UTILIZING A NON-INVASIVE MOTION SENSOR FOR MEASURING A VOLUME OF INSPIRATION US 63/710,394 Expired
NCATS E-042-2022-0-AU-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS AU National Stage 2023241585 Pending
NICHD E-115-2022-0-CA-01 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL CA National Stage 3250306 Pending
NICHD E-115-2022-0-IL-01 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL IL National Stage 316495 Pending
NCI E-143-2024-0-US-01 METHODS OF PREPARING CELL THERAPY PRODUCTS FOR THE TREATMENT OF CONDITIONS CAUSED BY HUMAN PAPILLOMAVIRUS 6 OR 11 INFECTION US 63/709,683 Expired
NCI E-112-2022-0-US-02 GENETICALLY ENGINEERED CELLS, THEIR USES, AND METHODS OF MAKING SAME US National Stage 18/858,315 Pending
NIAID E-216-2021-0-HK-01 SELF-ASSEMBLING NANOPARTICLES BASED ON AMPHIPHILIC PEPTIDES FOR DRUG DELIVERY APPLICATIONS HK EP 62024098282.2 Pending
NCATS E-042-2022-0-EP-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS EP National Stage 23721051.3 Pending
NEI E-249-2023-0-US-01 ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY (EIS) DEVICE TO RESOLVE INDIVIDUAL MEMBRANE ELECTRICAL PROPERTIES OF EPITHELIAL AND ENDOTHELIAL TISSUES US 63/708,904 Expired
NHLBI E-239-2023-0-PC-01 PRAZOLE-BASED ANTIVIRAL THERAPEUTICS PCT PCT PCT/US2024/052025 Pending
NIAID E-073-2022-0-EP-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE EP National Stage 23718605.1 Pending
NIAID E-080-2022-0-EP-01 BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE EP National Stage 23718600.2 Pending
NCI E-065-2025-0-US-01 IMMUNOGENS AND METHODS FOR INDUCING AN IMMUNE RESPONSE US 63/708,594 Expired
NCI E-041-2018-0-EP-01 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER EP DIV 24206864.1 Pending
NHLBI E-224-2024-0-US-01 IL-2 MUTEINS AND THEIR USE US 63/707,970 Expired
NCI E-125-2024-0-US-01 INTEGRASE STRAND TRANSFER INHIBITORS US 63/707,882 Expired
NCI E-188-2025-0-US-01 AUTOPHAGY MODULATORS AND METHODS OF USE US 63/707,961 Expired
NHLBI E-119-2022-0-IL-01 SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE IL National Stage 316418 Pending